Department of Medicine, Dr.Pinnamaneni Siddhartha Institute of Medical Sciences & Research Foundation, India.
Department of Medicine, Sargodha Medical College, Pakistan.
J Stroke Cerebrovasc Dis. 2024 Aug;33(8):107818. doi: 10.1016/j.jstrokecerebrovasdis.2024.107818. Epub 2024 Jun 11.
Since the efficacy and safety of endovascular thrombectomy (EVT) in patients with acute ischemic stroke with a large infarct area is still inconclusive, we sought to compare functional and neurological outcomes with the use of endovascular thrombectomy versus medical care alone.
We searched MEDLINE (via PubMed), Embase, Cochrane Library, ClinicalTrials.gov, and the International Clinical Trials Registry Platform (ICTRP) to retrieve all the relevant randomized controlled trials (RCTs) on this topic. Review manager (RevMan) was used to perform meta-analyses using a random-effect model. Dichotomous outcomes were pooled using risk ratios (RR) with 95% confidence intervals (CIs).
Our meta-analysis included 6 RCTs with a total of 1665 patients. Most studies included patients with an ASPECTS score of 3-5. Our results demonstrate that endovascular thrombectomy significantly increased the rates of functional independence (mRS ≤ 2) (RR, 2.49; 95% CI, 1.89-3.29) and moderate neurological outcome (mRS ≤ 3) (RR, 1.90; 95% CI, 1.50-2.40) at 90 days. The benefit of EVT for these outcomes remained the same at 1-year follow-up. Endovascular thrombectomy was associated with increased rates of early neurological improvement (RR, 2.22; 95% CI, 1.53-3.22), excellent neurological recovery (mRS ≤ 1) (RR, 1.75; 95% CI, 1.02-3.03), and decreased rate of poor neurological recovery (mRS 4-6) (RR, 0.81; 95% CI, 0.76-0.86). No significant difference was found between the two groups regarding all-cause mortality (RR, 0.86; 95% CI, 0.72-1.02), decompressive craniectomy (RR, 1.32; 95% CI, 0.89-1.94), and the incidence of serious adverse effects (RR, 1.39; 95% CI, 0.83-2.32) between the two groups. Endovascular thrombectomy significantly increased the rates of any intracranial hemorrhage (RR, 1.94; 95% CI, 1.48-2.53) and symptomatic intracranial hemorrhage (RR, 1.73; 95% CI, 1.11-2.69).
Endovascular thrombectomy (EVT) significantly improves neurological and functional outcomes in patients who present within 6 hours of stroke onset with ICA and proximal M1 occlusions, and ASPECTS scores ranging from 3 to 5, compared to medical therapy alone, with an increased risk of symptomatic intracranial hemorrhage.
由于血管内血栓切除术(EVT)治疗大面积梗死区急性缺血性脑卒中的疗效和安全性仍存在争议,因此我们旨在比较血管内血栓切除术与单纯药物治疗在改善功能和神经功能结局方面的效果。
我们检索了 MEDLINE(通过 PubMed)、Embase、 Cochrane 图书馆、ClinicalTrials.gov 和国际临床试验注册平台(ICTRP),以检索该主题的所有相关随机对照试验(RCT)。使用 Review Manager(RevMan)软件采用随机效应模型进行荟萃分析。使用风险比(RR)和 95%置信区间(CI)汇总二分类结局。
我们的荟萃分析纳入了 6 项 RCT,共计 1665 例患者。大多数研究纳入了 ASPECTS 评分为 3-5 分的患者。我们的研究结果表明,与单纯药物治疗相比,血管内血栓切除术可显著提高 90 天内功能独立性(mRS≤2 分)(RR,2.49;95%CI,1.89-3.29)和中度神经功能结局(mRS≤3 分)(RR,1.90;95%CI,1.50-2.40)的发生率。在 1 年随访时,EVT 治疗这些结局的获益仍保持不变。血管内血栓切除术可增加早期神经功能改善(RR,2.22;95%CI,1.53-3.22)、良好神经恢复(mRS≤1 分)(RR,1.75;95%CI,1.02-3.03)的发生率,降低不良神经恢复(mRS 4-6 分)(RR,0.81;95%CI,0.76-0.86)的发生率。两组之间全因死亡率(RR,0.86;95%CI,0.72-1.02)、去骨瓣减压术(RR,1.32;95%CI,0.89-1.94)和严重不良事件发生率(RR,1.39;95%CI,0.83-2.32)差异无统计学意义。血管内血栓切除术可显著增加任何颅内出血(RR,1.94;95%CI,1.48-2.53)和症状性颅内出血(RR,1.73;95%CI,1.11-2.69)的发生率。
与单纯药物治疗相比,血管内血栓切除术(EVT)可显著改善发病 6 小时内出现 ICA 和近端 M1 闭塞、ASPECTS 评分 3-5 分的患者的神经功能和功能结局,但会增加症状性颅内出血的风险。